Xeris Biopharma Holdings Inc (XERS)

Income Before Tax

-$31.10M

Quarterly · Period ending: · USD

XERS logo

XERS Income Before Tax

Latest reported-$31.10M
XERS Quarterly Pre-Tax Income (-$4.65M → -$31.10M)
High-resolution chart · PNG

XERS income before tax history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Xeris Biopharma Holdings Inc Income Before Tax — Quarterly (USD)
Period endingIncome Before Tax (USD)
-31,101,000
2,234,000
11,081,000
621,000
-1,928,000
-9,220,000
-5,113,000
-19,062,000
-14,256,000
-18,673,000
-13,626,000
-12,527,000
-20,517,000
-16,834,000
-13,268,000
-22,170,000
-26,524,000
-34,122,000
-50,790,000
-26,009,000
-27,515,000
-18,411,000
-21,857,000
-16,000,000
-24,209,000
-29,184,000
-33,540,000
-32,836,000
-34,385,000
-25,277,000
-20,419,000
-14,767,000
-12,987,000
-11,907,000
-9,146,000
-7,527,000
-5,232,000
-4,649,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.